Skip to content

MaxCyte MXCT Short-Term Investments

Short-Term Investments at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$1.01B-14.1%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$11.33M
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$9.13M-59.9%
PDE
Pro-Dex, Inc.PDEX
$986K+23.7%
Repligen logo
RepligenRGEN
$201.88M
Prime Medicine logo
Prime MedicinePRME
$71.39M

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's short-term investments?
MaxCyte (MXCT) reported short-term investments of $92.3M in Q1 2026.
How has MaxCyte's short-term investments changed year-over-year?
MaxCyte's short-term investments decreased by 19.7% year-over-year, from $114.89M to $92.3M.
What is the long-term trend for MaxCyte's short-term investments?
Over 5 years (2020 to 2025), MaxCyte's short-term investments has grown at a 39.0% compound annual growth rate (CAGR), from $16.01M to $82.98M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.